ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
129.922,38
0,69%
S&P 500
6.021,63
0,57%
US Dollar vs BRL
5,8129
0,03%
Bitcoin
93.402,94
1,56%
Brent Oil
72,625
0,24%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Pathfinder Cell Therapy Inc (CE) (PFND)

  7. Pathfinder Cell Therapy Inc (CE) (PFND) Notícias

PFND

Pathfinder Cell Therapy (CE) (PFND)

Pathfinder Cell Therapy Inc (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:PFND
DataHoraFonteTítuloCódigoCompanhia
05/04/201607:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201617:16Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/03/201618:26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/03/201616:26Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/03/201614:40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
13/11/201514:23Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
31/03/201513:19Edgar (US Regulatory)Annual Report (10-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
27/05/201417:25Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/04/201414:39Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
31/03/201416:52Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
14/08/201316:13Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
06/03/201319:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/01/201311:28Edgar (US Regulatory)Current report filing (8-K)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
28/12/201214:01Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
07/12/201216:04Edgar (US Regulatory)Certified Annual Shareholder Report for Management Investment Companies (n-csr)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/05/201211:26Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/04/201215:06Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201213:40Edgar (US Regulatory)Annual Report (10-K)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
21/02/201211:01GlobeNewswire Inc.Pathfinder Presents Preliminary Data on New Regenerative Approach to Diabetes TreatmentUSOTC:PFNDPathfinder Cell Therapy Inc (CE)
16/02/201211:00GlobeNewswire Inc.Pathfinder to Present at New York Stem Cell SummitUSOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/02/201211:00GlobeNewswire Inc.Pathfinder Announces First European Patent Allowance for Pathfinder CellsUSOTC:PFNDPathfinder Cell Therapy Inc (CE)
05/01/201221:13Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
16/12/201119:34Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/12/201121:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
13/12/201113:00GlobeNewswire Inc.Pathfinder Cell Therapy Provides Update on Pathfinder Cell Research and DevelopmentUSOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/11/201120:13Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/10/201117:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:PFND

Seu Histórico Recente

AMEX
IQSI
NYLI Candriam Internatio...
BOV
BMEB3
BANCO MERCANTIL ON
TSXV
HOH
High Arctic Overseas
BOV
CEBR6
CEB PNB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 60%* para TRADER PLUS

1 ano 40%, 2 anos 50% e *3 anos 60%

*Ao longo de 3 anos $ 1475.65 apenas $ 590.25